Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00312936 · ClinicalTrials.gov registry record · Phase 1

A Mindfulness Based Approach to HIV Treatment Side Effects

A Phase 1 study, sponsored by University of California, San Francisco.

Completed
Registry status
Phase 1
Development phase
76
Enrollment target

NCT00312936: Completed Phase 1 study, sponsored by University of California, San Francisco.

NCT00312936 is a Phase 1 study that has completed, run by University of California, San Francisco. The registered enrollment target is 76 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (27% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00312936, a Phase 1 study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
Phase 1
Development phase
76 participants
Enrollment target

Study Summary

We are exploring the effect that an 8 week stress reduction program based in mindfulness practices will have on the experience of medication side effects reported by HIV-infected men and women taking antiretroviral therapy.

Interventions

  • BEHAVIORAL Mindfulness-based Stress Reduction (MBSR)

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2006-07
Est. Completion 2008-10
Phase Phase 1

What the finished NCT00312936 record still lists

NCT00312936 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (27% higher).

The record links to 0 conditions, and to 1 intervention - of which Mindfulness-based Stress Reduction (MBSR) is the first listed.

NCT00312936 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00312936 about?

NCT00312936 is a clinical study titled "A Mindfulness Based Approach to HIV Treatment Side Effects". We are exploring the effect that an 8 week stress reduction program based in mindfulness practices will have on the experience of medication side effects reported by HIV-infected men and women taking antiretroviral therapy.

What is the current status of trial NCT00312936?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 76 participants. The study started on 2006-07. Estimated completion is 2008-10.

What interventions are being tested in trial NCT00312936?

The interventions under investigation include: Mindfulness-based Stress Reduction (MBSR) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00312936?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00312936's enrollment target sits among peer trials

76 705th of 2000 higher than 1,290 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02615184 · 76 participants · Phase 2

    A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old

  • NCT02821741 · 76 participants · NA

    Effects of External Ear Stimulation on Pain Perception and Mood

  • NCT03019757 · 76 participants

    Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

  • NCT03353584 · 76 participants · NA

    Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00312936, the US trial registry maintained by the National Library of Medicine. NCT00312936 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.